Biden Administration Plans to Offer Updated Booster Shots in September

With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

N.Y.C. to Offer Paxlovid at Mobile Virus Test Sites, First in U.S.

Mayor Eric Adams says that offering immediate prescriptions to people who test positive at the mobile sites will help address concerns over inequities in distributing antiviral treatments.

#adams-eric-l, #coronavirus-2019-ncov, #jha-ashish-1970, #new-york-city, #paxlovid-drug, #pfizer-inc, #tests-medical

Fauci, Recovering From ‘Rebound’ of Covid, Praises Paxlovid

Dr. Anthony Fauci, President Biden’s top pandemic adviser, sought to discourage doubts about the antiviral drug Paxlovid following what appeared to be a “rebound” of Covid-19 after taking the pills.

#coronavirus-2019-ncov, #fauci-anthony-s, #paxlovid-drug, #pfizer-inc, #vaccination-and-immunization

Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions

The vaccines seem safe for children and are likely to protect against severe illness. But data on efficacy are thin, and most children have already been infected.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #moderna-inc, #parenting, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

F.D.A. Authorizes Moderna and Pfizer Covid Vaccines for Youngest Children

A recommendation from the C.D.C. director would be the final step before doses are rolled out for the roughly 20 million children under the age of 5.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization

A Better Way to Measure Immunity in Children

Some scientists believe that a clearer picture of Covid vaccine efficacy could have emerged sooner if investigators had tracked certain immune cells, not just antibodies.

#antibodies, #biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #immune-system, #moderna-inc, #parenting, #pfizer-inc, #tests-medical, #vaccination-and-immunization, #your-feed-science

Relief for Parents

Covid vaccines for young children are finally coming.

#children-and-childhood, #coronavirus-2019-ncov, #internal-storyline-no, #moderna-inc, #parenting, #pfizer-inc, #vaccination-and-immunization

F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children

States have already ordered millions of doses; if the agency authorizes them in the coming days, babies, toddlers and preschoolers could start receiving shots next week.

#biontech-se, #centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #walensky-rochelle

Pfizer Vaccine Effective in Children Under 5, the F.D.A. Says

Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest children.

#biontech-se, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization

C.D.C. Advisers Recommend Pfizer Boosters for Children 5 to 11.

A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have received two doses.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #pfizer-inc, #united-states, #vaccination-and-immunization

The Covid Pandemic Still Isn’t Over. So What Now?

Reinfection may become the norm even for people who have received several vaccine doses.

#coronavirus-2019-ncov, #debatable, #inventions-and-patents, #long-covid, #moderna-inc, #paxlovid-drug, #pfizer-inc

The F.D.A. authorizes Pfizer-BioNTech boosters for children ages 5 to 11.

More than eight million of the 28 million children in that age group in the United States have received two vaccine shots.

#biontech-se, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A. Expected to Soon Clear Pfizer Booster for Children Ages 5 to 11

Given that the age group has the lowest coronavirus vaccination rate of all eligible Americans, public health experts are not expecting a rush for the booster.

#biontech-se, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #pfizer-inc, #united-states, #vaccination-and-immunization

F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5

Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for the youngest children.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states, #vaccination-and-immunization

Did Faulty Assumptions Dash Parents’ Hope for an Under-5 Vaccine?

The under-5 Covid vaccine should be approved.

#centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #coronavirus-risks-and-safety-concerns, #disease-rates, #food-and-drug-administration, #immune-system, #masks, #moderna-inc, #pfizer-inc, #tests-medical, #vaccination-and-immunization

Covid Drugs Save Lives, but Americans Can’t Get Them

Once again, a dysfunctional health care system has hindered our pandemic response.

#coronavirus-2019-ncov, #doctors, #drugs-pharmaceuticals, #evusheld-drug, #health-insurance-and-managed-care, #paxlovid-drug, #pfizer-inc, #united-states, #vaccination-and-immunization

Pfizer Says Booster Strengthens Immune Response for Children 5 to 11

Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.

#biontech-se, #children-and-childhood, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A. Panel Weighs Challenges of Revamping Covid Vaccines for Fall

A meeting of the committee underscored how many uncertainties lie ahead, including whether a vaccine that works better against variants can be ready by fall.

#centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #health-and-human-services-department, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Older

People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies are also eligible.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Getting Covid Shots in the Littlest Arms Might Not Be That Easy

Authorization is one step; it’ll take time to resolve confusion and hesitancy.

#coronavirus-2019-ncov, #coronavirus-omicron-variant, #instagram-inc, #internal-sub-only-nl, #kaiser-family-foundation, #moderna-inc, #parenting, #pfizer-inc, #vaccination-and-immunization

Biden Administration Likely to Offer Older Americans Second Booster Shots

Federal officials appear to be coalescing around a plan to offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again soon.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization

Sinovac Booster Gives Elderly Stronger Protection Against Omicron, Study Finds

Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong.

#biontech-se, #china, #coronavirus-2019-ncov, #disease-rates, #hong-kong, #pfizer-inc, #research, #sinovac-biotech-ltd, #vaccination-and-immunization, #your-feed-healthcare

Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Children

The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.

#biontech-se, #centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk

The move follows recalls of other medications found to have higher levels of potential carcinogens.

#accuretic, #benzene, #cancer, #drugs-pharmaceuticals, #food-and-drug-administration, #metformin, #n-nitrosodimethylamine, #ndma, #nitrosamine, #pfizer-inc, #ranitidine, #recalls-and-bans-of-products, #valisure, #valsartan, #your-feed-healthcare

Should You Get a 4th Covid Shot?

Experts say that the most vulnerable would benefit from a second booster soonest.

#antibodies, #content-type-service, #coronavirus-2019-ncov, #elderly, #immune-system, #pfizer-inc, #vaccination-and-immunization

Pfizer Seeks Authorization of a Second Booster Shot for Older Americans

The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #elderly, #food-and-drug-administration, #national-institutes-of-health, #pfizer-inc, #research, #vaccination-and-immunization

The J.&J. Vaccine Holds Its Own as Virus Data Grows

Once dismissed as less effective, the vaccine now seems to be preventing infections and illness about as well as the two mRNA options.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #disease-rates, #johnsonjohnson, #moderna-inc, #pfizer-inc, #vaccination-and-immunization, #your-feed-science

Which Coronavirus Vaccine Will Work in the Youngest Children?

Moderna is going head-to-head with Pfizer-BioNTech for the opportunity to vaccinate the youngest children, the only Americans still not eligible for shots.

#biontech-se, #centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #research, #united-states, #vaccination-and-immunization

New Vaccine Findings Pose Tough Questions for Parents of Young Children

The F.D.A. temporarily halted efforts to authorize the Pfizer-BioNTech vaccine for young children amid several unexpected findings. The coming weeks should bring clarity.

#centers-for-disease-control-and-prevention, #children-and-childhood, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #food-and-drug-administration, #immune-system, #moderna-inc, #parenting, #pfizer-inc, #protective-clothing-and-gear, #teenagers-and-adolescence, #united-states, #vaccination-and-immunization, #your-feed-science

We’re Entering a Period of Relatively Low Covid Risk for Kids

Despite so-so vaccine news for children 5-11.

#clinical-trials, #coronavirus-omicron-variant, #instagram-inc, #internal-sub-only-nl, #masks, #new-york-city, #pfizer-inc, #twitter, #vaccination-and-immunization

Viatris Settles EpiPen Antitrust Litigation for $264 Million

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100.

#compensation-for-damages-law, #epinephrine-drug, #epipen, #medical-devices, #mylan, #pfizer-inc, #suits-and-litigation-civil, #viatris

Will Adults Need a Fourth Dose of Covid Vaccine? It’s Too Soon to Know.

A Food and Drug Administration official said the best time for an additional shot may be fall, when the spread of the coronavirus is expected to pick up again

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #vaccination-and-immunization

Covid Vaccines for Kids Under 5: What Parents Should Know

Here’s what families should know about the delay.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-risks-and-safety-concerns, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

F.D.A Delays Review of Pfizer’s Covid Vaccine for Children Under 5

The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

The Next Vaccine Debate: Immunize Young Children Now, or Wait?

It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.

#biontech-se, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #immune-system, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

What’s Going on With Vaccines for Kids Under 5?

It’s confusing, but don’t freak out.

#biontech-se, #bronx-nyc, #coronavirus-2019-ncov, #internal-sub-only-nl, #kaiser-family-foundation, #parenting, #pfizer-inc, #twitter, #vaccination-and-immunization

Pfizer Asks F.D.A. to Clear 2 Vaccine Doses for Young Children as a Start

The Food and Drug Administration asked to review Pfizer’s data on two doses now, while the company continues to assess whether three doses would be more effective.

#centers-for-disease-control-and-prevention, #children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #food-and-drug-administration, #pfizer-inc, #vaccination-and-immunization

Unilever Pursues Glaxo and Pfizer Consumer Health Venture

Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.

#cold-and-cold-spells, #drugs-pharmaceuticals, #glaxosmithkline-plc, #london-england, #mergers-acquisitions-and-divestitures, #pfizer-inc, #unilever-nv

Covid Treatments Including Paxlovid Are Rationed as Cases Spike

Scarce supplies and surging Covid cases have caused health officials, hospitals, doctors and patients to scramble for pills and infusions.

#antibodies, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #glaxosmithkline-plc, #hospitals, #paxlovid-drug, #pfizer-inc, #rationing-and-allocation-of-resources

Biden Administration Doubles Order of Pfizer’s Covid Pill

President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.

#biden-joseph-r-jr, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #paxlovid-drug, #pfizer-inc, #tests-medical

F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

Regulators will also allow even younger children with immune deficiencies to get an extra shot.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #pfizer-inc, #teenagers-and-adolescence, #vaccination-and-immunization, #walensky-rochelle

Bosses Have a New Headache: How Long Should Sick Workers Isolate?

Amid staffing shortages, companies are weighing conflicting guidance on when employees who have tested positive for the coronavirus can safely return to work.

#airlines-for-america, #brooklyn-nyc, #brown-university, #centers-for-disease-control-and-prevention, #city-practice-group-of-new-york-citymd, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #delta-air-lines-inc, #doordash-mobile-app, #harvard-university, #hochul-kathleen-c, #jetblue-airways-corporation, #jha-ashish-1970, #merckcompany-inc, #national-football-league, #pfizer-inc, #quarantines, #scripps-research-institute, #society-for-human-resource-management, #target-corporation, #workplace-hazards-and-violations

F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Older

The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.

#clinical-trials, #coronavirus-delta-variant, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #molnupiravir-drug, #paxlovid-drug, #pfizer-inc, #your-feed-science

Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysis

The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.

#clinical-trials, #coronavirus-delta-variant, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #molnupiravir-drug, #paxlovid-drug, #pfizer-inc, #your-feed-science

Pfizer Says Its Booster Is Effective Against Omicron

The company’s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.

#antibodies, #biontech-se, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #pfizer-inc, #vaccination-and-immunization

Pfizer says blood samples from people who got three of its doses show robust antibody levels against Omicron.

#antibodies, #biontech-se, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #pfizer-inc, #united-states, #vaccination-and-immunization

Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?

The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.

#antibodies, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #income-inequality, #merckcompany-inc, #pfizer-inc, #tests-medical, #your-feed-health, #your-feed-science

We Got a Head Start on Omicron, So Let’s Not Blow It

South Africa gave the world an early warning. Decisive action on containment and surveillance could help us control it.

#biden-joseph-r-jr, #coronavirus-2019-ncov, #coronavirus-delta-variant, #moderna-inc, #pfizer-inc, #quarantines, #travel-warnings, #vaccination-and-immunization

C.D.C. Endorses Covid Vaccine Booster Shots for All Adults

As infections rise, Americans over 18 will be permitted to get extra doses. But it’s not clear boosters really are needed by so many people, or that the shots will turn back the pandemic.

#biontech-se, #centers-for-disease-control-and-prevention, #coronavirus-2019-ncov, #coronavirus-delta-variant, #coronavirus-risks-and-safety-concerns, #disease-rates, #food-and-drug-administration, #pfizer-inc, #united-states, #vaccination-and-immunization, #your-feed-science

F.D.A. Authorizes Coronavirus Booster Shots for All Adults

If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by this weekend.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #moderna-inc, #pfizer-inc, #united-states-politics-and-government, #vaccination-and-immunization